Tenecteplase biosimilar (Bio-tianjie)

替奈普酶生物类似药 (Bio-tianjie)

Report date: 2026/05/20 20:02:01

Base Information

Drug NameTenecteplase biosimilar (Bio-tianjie)
Drug Alias Name替尼普酶生物仿制药 (Bio-tianjie)tenecteplase biosimilar(Beijing The Place Bio-Tech)奈替普酶生物仿制药 (Bio-tianjie)特奈替普酶生物仿制药 (Bio-tianjie)替奈普酶生物仿制药 (Bio-tianjie) +[7] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPlasminogen stimulants
TargetsPlasminogen
Therapy Area/IndicationsStrokePulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing The Place Bio-Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFenghua Biological Co., Ltd.Shanghai Fenghua Tianlitong Biomedical Co LtdJiangsu Fangqiang Pharmaceutical Factory Co Ltd
Inactive CompaniesN/A
Active IndicationsStrokePulmonary Embolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AD11
Related LinksN/A